Healthcare Pharmaceuticals is involved in the pharmaceuticals sector, providing healthcare-related products and services.

Healthcare Pharmaceuticals

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

NantHealth, Inc.

PharmaBangla is a Bangla language website focused on pharmacy-related content.

PharmaBangla

Emmetropia is an ophthalmology center providing diagnosis and recovery for vision problems.

Metric
Company Name	Healthcare Pharmaceuticals	NantHealth, Inc.	PharmaBangla	EYE CLINIC EMMETROPIA
Symbol		NH
MSH ID	COM:HPLBD	COM:NANTHEALTH	COM:PHARMABANGLA	GR:OFTHALMOLOGIKOKENTROEMMETROPIA
Market	PRIVATE	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare	Healthcare & Health Services	Healthcare & Health Services
Industry	Pharmaceuticals	Medical - Healthcare Information Services	Pharmaceuticals	Medical Services
Country	BD	US	BD	GR
Stage
Employee Count		365
Website	hplbd.com	nanthealth.com	pharmabangla.com	ofthalmologikokentroemmetropia.gr/en
LinkedIn
Founders

Metric
Market Cap		10.40M
Enterprise Value
Monthly Web Traffic	20.34K
Web Traffic Growth	0.50
Valuation
Raised Capital

Metric
Revenue		67.00M
Revenue (LTM)
Revenue (NTM)
Gross Profit		38.16M
EBITDA		-37.98M
Operating Income		-51.33M
Net Income		-67.78M
EPS		-8.80
Diluted EPS		-8.80
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.61
Operating Profit Margin		-0.69
EBITDA Margin		-0.57
Net Profit Margin		-1.09
Return on Equity		0.29
Return on Assets		-0.48
Return on Capital Employed		1.00

COM:HPLBD

Healthcare Pharmaceuticals

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-0.16
P/B Ratio		-0.04
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		0.16
EV Multiple		1.93

Metric
Days Sales Outstanding		38.87
Days Payables Outstanding		126.87
Days Inventory Outstanding
Operating Cycle		25.99
Cash Conversion Cycle		-71.70
Asset Turnover		0.44

Metric
Operating Cash Flow		-32.26M
Free Cash Flow		-38.73M
Cash Flow to Debt		-0.14
Operating Cash Flow/Sales		-0.21
Free Cash Flow Yield		-3.30

Metric
Cash & Equivalents		1.76M
Accounts Receivable		-204K
Inventory		2.75M
Goodwill		98.33M
Debt to Capitalization		-0.65
Debt to Assets		1.70
Current Ratio		0.64
Quick Ratio		0.05

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.06
R&D to Revenue		0.33
SG&A to Revenue